Bonalive obtains MDR

The company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic control of Realheart TAH.

On September 16, OsteoCentric announced that approximately 69.4 percent of the shares in Integrum had been tendered and that the offer will not be completed as the 90 percent acceptance condition was not satisfied.

FluoGuide has received positive feedback and alignment with the FDA at a pre-IND consultation on its U.S. clinical study design.

Health Net Connections Limited (HNC) is a provider of healthcare software for digital diagnostic imaging, ultrasound reporting and secure data-exchange to hospitals and private clinics across the UK. 

VibroSense Dynamics has received an Intention to Grant from the European Patent Office (EPO) regarding a patent on a biomarker to predict the risk of developing permanent nerve damage after cancer treatment with chemotherapy.

The independent bid committee of Integrum has decided to recommend that the shareholders accept OsteoCentric Oncology and Bone Anchored Prostheses, LLC’s public takeover offer.

The objective of the collaboration is to develop FG001 for tumor imaging and surgical margins assessment for head and neck cancer.